By Stephen J. (editor) Lippard
Read or Download Platinum, Gold, and Other Metal Chemotherapeutic Agents. Chemistry and Biochemistry PDF
Similar pharmacology books
Eli Lily and corporate, Greenfield, identification. Reference offering an up to date evaluation of enzyme capabilities in human and animal future health, together with assurance of latest and rising applied sciences in biotechnical and pharmaceutical industries. Emphasizes smooth equipment of metabolic engineering and drug discovery techniques, and information enzymes with regards to human ailment.
Must-know information regarding a thousand of the main accepted medictions -- at your fingertips and able to use! compliment for a prior version: "This is a truly precious and updated pocket reference for wide-spread medicines. five Stars! "--Doody's evaluate provider Why spend time plowing via info you don't want whilst what you actually need to understand is correct right here in a single concise consultant?
It is a 3-in-1 reference publication. It offers an entire clinical dictionary protecting 1000's of phrases and expressions in relation to warfarin. It additionally offers large lists of bibliographic citations. eventually, it offers details to clients on tips to replace their wisdom utilizing a variety of net assets.
- Pharmacology of Antihypertensive Therapeutics
- Multiplex Biomarker Techniques: Methods and Applications
- Lipases and Phospholipases in Drug Development: From Biochemistry to Molecular Pharmacology
- Intelligent Drug Development: Trials and Errors in Clinical Research
- Handbook of Psychiatric Drug Therapy (Lippincott Williams & Wilkins Handbook Series)
Additional resources for Platinum, Gold, and Other Metal Chemotherapeutic Agents. Chemistry and Biochemistry
Showed that both compounds can produce SCE, thus SCE producTion can be d i s s o c i a t e d from mutagenicity (16). ; ACS Symposium Series; American Chemical Society: Washington, DC, 1983. 42 METAL CHEMOTHERAPEUTIC AGENTS Table I I . 19 18 Source: a b <10~ 5 1303 2300 880 1200 522 Reference 3. S u r v i v a l of colony-forming a b i l i t y . HGPRT l o c u s . ; ACS Symposium Series; American Chemical Society: Washington, DC, 1983. 40 99 79 116 106 2. ch002 ~ι Crosslinks 43 Γ 4 3x10" m 2x10" Ξ ce 4 I 1x10- οί ο JL _L 5 100 200 15 μΜ c/s-DDP 10 300 400 500 600 μΜ trans-DDP DRUG CONCENTRATION Figure 10.
W. "Cisplatin. Current Status and New Developments"; Prestayko, A. ; Crooke, S. ; Carter S. K. ; Academic Press: New York, 1980; pp. 21-35. ; ACS Symposium Series; American Chemical Society: Washington, DC, 1983. 3 Structural Chemistry of P l a t i n u m - D N A Adducts THOMAS D. TULLIUS, H. MICHAEL USHAY, CAROLYN M. MERKEL, JOHN P. CARADONNA, and STEPHEN J. ch003 Columbia University, Department of Chemistry, New York, NY 10027 Aspects of the binding of the antitumor drug, cis-diamminedichloroplatinum(II) (cis-DDP), and other platinum complexes to DNA are reviewed.
Proteolytic enzymes can be used to distinguish DPC from ISC. DPC form rapidly and are the major lesion produced by trans-DDP. ISC form over 6-12 hr following treatment and are more efficiently formed by cis-DDP. ISC correlated more closely with cytotoxicity than did DPC. This was confirmed using chemical blockade of ISC formation to enhance cell survival following cis-DDP treatment. Additionally, malignant cells resistant to cis-DDP in vitro and in vivo showed lower levels of ISC than their sensitive parent lines.